Decline in the frequencies of Borrelia burgdorferi OspA161-175- specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory Lyme arthritis

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 6336-6342

  Kannian, Priya ^a   Drouin, Elise E ^a   Glickstein, Lisa ^a   Kwok, William W ^b   Nepom, Gerald T ^b   Steere, Allen C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CEFTRIAXONE; DOXYCYCLINE; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; OUTER SURFACE PROTEIN A; TETRAMER; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; HLA-DRB1 ANTIGEN; IMMUNOGLOBULIN G; OSPC PROTEIN; OUTER MEMBRANE PROTEIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CD4+ T LYMPHOCYTE; CHILD; HUMAN; HUMAN CELL; LYME DISEASE; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SYNOVIAL FLUID; SYNOVITIS; T LYMPHOCYTE; TREATMENT RESPONSE; ANTIBIOTIC RESISTANCE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA BURGDORFERI; CELL PROLIFERATION; CELLS, CULTURED; DRUG RESISTANCE, BACTERIAL; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LYME DISEASE; PEPTIDE FRAGMENTS; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 38449121494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.6336     Document Type: Article

References (31)

1. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345: 115-125.
2. Steere, A. C., R. T. Schoen, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107: 725-731.
3. Steere, A. C., R. E. Levin, P. J. Molloy, R. A. Kalish, J. H. Abraham III, N. Y. Liu, and C. H. Schmid. 1994. Treatment of Lyme arthritis. Arthritis Rheum. 37: 878-888.
4. Dattwyler, R. J., G. P. Wormser, T. J. Rush, M. F. Finkel, R. T. Schoen, E. Grunwaldt, M. Franklin, E. Hilton, G. L. Bryant, W. A. Agger, and D. Maladorno. 2005. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien. Klin. Wochenschr. 117: 393-397.
5. Steere, A. C., and S. M. Angelis. 2006. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 54: 3079-3086.
6. Nocton, J. J., F. Dressler, B. J. Rutledge, P. N. Rys, D. H. Persing, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330: 229-234.
7. Carlson, D., J. Hernandez, B. J. Bloom, J. Coburn, J. M. Aversa, and A. C. Steere. 1999. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42: 2705-2709.
8. Steere, A. C., E. Dwyer, and R. Winchester. 1990. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323: 219-223.
9. Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61: 2774-2779.
10. Lengl-Janssen, B., A. F. Strauss, A. C. Steere, and T. Kamradt. 1994. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180: 2069-2078.
11. Gross, D. M., T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281: 703-706.
12. Chen, J., J. A. Field, L. Glickstein, P. J. Molloy, B. T. Huber, and A. C. Steere. 1999. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum. 42: 1813-1822.
13. 161-175 T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. J. Autoimmun. 23: 281-292.
14. Ausubel, L. J., K. C. O'Connor, C. Baecher-Allen, C. Trollmo, B. Kessler, B. Hekking, D. Merritt, A. L. Meyer, B. Kwok, H. Ploegh, et al. 2005. Characterization of in vivo expanded OspA-specific human T-cell clones. Clin. Immunol. 115: 313-322.
15. Steere, A. C., W. Klitz, E. E. Drouin, B. A. Falk, W. W. Kwok, G. T. Nepom, and L. A. Baxter-Lowe. 2006. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J. Exp. Med. 203: 961-971.
16. Steere, A. C., B. Falk, E. E. Drouin, L. A. Baxter-Lowe, J. Hammer, and G. T. Nepom. 2003. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48: 534-540.
17. Steere, A. C., and L. Glickstein. 2004. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4: 143-152.
18. + T cells. Arthritis Rheum. 46: 5-12.
19. Kwok, W. W. 2003. Challenges in staining T cells using HLA class II tetramers. Clin. Immunol. 106: 23-28.
20. Meyer, A. L., C. Trollmo, F. Crawford, P. Marrack, A. C. Steere, B. T. Huber, J. Kappler, and D. A. Hafler. 2000. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc. Natl. Acad. Sci. USA 97: 11433-11438.
21. Wormser, G. P., R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere, M. S. Klempner, P. J. Krause, J. S. Bakken, F. Strle, G. Stanek, et al. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43: 1089-1134.
22. Wharton, M., T. L. Chorba, R. L. Vogt, D. L. Morse, and J. W. Buehler. 1999. Case definitions for public health surveillance Morbid. Mortal. Wkly. Rep. 39: 1-43.
23. Centers for Disease Control. 1995. Notice to readers: recommendations for test performance and interpretation from the Second National Conference on the Serological Diagnosis of Lyme Disease. Morbid. Mortal. Wkly. Rep. 44: 590-591.
24. + T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104: R63-R67.
25. Day, C. L., N. P. Seth, M. Lucas, H. Appel, L. Gauthier, G. M. Lauer, G. K. Robbins, Z. M. Szczepiorkowski, D. R. Casson, R. T. Chung, et al. 2003. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112: 831-842.
26. Vaz, A., L. Glickstein, J. A. Field, G. McHugh, V. K. Sikand, N. Damle, and A. C. Steere. 2001. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect. Immun. 69: 7437-7444.
27. Lucas, M., C. L. Day, J. R. Wyer, S. L. Cunliffe, A. Loughry, A. J. McMichael, and P. Klenerman. 2004. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 78: 7284-7287.
28. Kannian, P., G. McHugh, B. J. B. Johnson, R. M. Bacon, L. J. Glickstein, and A. C. Steere. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum. In press.
29. αL is a partial agonist for OspA-reactive T cells. J. Immunol. 166: 5286-5291.
30. Drouin, E. E., L. J. Glickstein, W. W. Kwok, G. T. Nepom, and A. C. Steere. 2008. Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Mol. Immunol. 45: 180-189.
31. Shin, J., L. J. Glickstein, and A. C. Steere. 2007. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum. 56: 1325-1335.